Get set for capital raise at Amarin after ANCHOR SPA rejection

"We believe the company will abandon attempts to gain approval for the indication meaning that Vascepa will only be approved for what appears to be a niche indication," says analyst William Tanner, reiterating his Market Perform rating and $2 price target on Amarin (AMRN -24.9%) following the FDA declining the reinstate the ANCHOR SPA.

Investors, he says, face significant dilution even if Amarin discontinues the REDUCE-IT trial. With $226M ($1.30 per share) in cash at the end of Q3 and an $80M/quarter burn rate this year ($30M-$40M for REDUCE-IT), the company has about two years of liquidity. "We doubt the company could achieve break-even status with just the MARINE indication."

From other sites
Comments (9)
  • Quoth the Raven
    , contributor
    Comments (2063) | Send Message
    Agreed - dilution coming, as first predicted here:
    21 Jan 2014, 11:23 AM Reply Like
  • framus_morrigan
    , contributor
    Comments (76) | Send Message
    Agreed, dilution coming in MORE THAN A YEAR!
    21 Jan 2014, 11:36 AM Reply Like
  • listech
    , contributor
    Comments (19) | Send Message
    Sadly, this is a company that appeared to do everything right but apparently didn't calculate the impact of the FDA's decision-making power.
    Too many people get caught up in how good it was and "how it couldn't lose". Not real good business-decision thinking and I was one of them! It's classic stock trader's wishful thinking!


    Learn by our mistakes and never make them again and we'll be ahead of the game!
    21 Jan 2014, 12:11 PM Reply Like
  • Rob Chanock
    , contributor
    Comments (251) | Send Message
    Meanwhile Sarepta, with nothing on the market is going up while Amarin, with a partially approved drug declines. Real logical stuff, this investing is.
    21 Jan 2014, 01:24 PM Reply Like
  • bidmark
    , contributor
    Comments (12) | Send Message
    How about expressing those "doubts" with facts?
    21 Jan 2014, 02:30 PM Reply Like
  • Santyapril
    , contributor
    Comments (87) | Send Message
    Can AMRN break into $3 in the next six months?
    21 Jan 2014, 02:34 PM Reply Like
  • Andrew Colburn
    , contributor
    Comments (139) | Send Message
    Interim Reduce-It results are expected in 2015. If positive deviation, they will have no problem raising cash if it is needed at all. Positive results would be a cash cow to any pharma. Lots of blustering going on by people who are so short sighted.
    21 Jan 2014, 06:10 PM Reply Like
  • writeme22
    , contributor
    Comments (7) | Send Message
    It is unfortunate, that most of the self ascribed " writers " here and on the other bashing and pumping platforms can't just write to expose the realities that are present in this saga, among the many others. Specifically, this story unfolding between Amarin and certain individuals working for or on behalf of Government Agencies too closely tied to big pharma is stuff that happens all too often and could be used for the big screen. Speaking of movies, The title- "Conspiracy Theory " has already been used so maybe something like, " David against Goliath And All The Kings Men " would do nicely.
    What we have here, just a few posts above mine, Raven for example, chime in to add the extra steam to this proverbial train wreck in the making. They have no real talents to offer their readers or their fellow man for that matter or reverence for science or the men and women behind the effort that at one point in time put our Nation on top of the heap. They remind me of the pushers of rhetoric by Tokyo Rose and the other Nazi pushers false logic through radio transmissions. Sadly, these paid corporate assassins, and these idolaters against earned success, whom, would sell their own mothers into bondage for a quick buck, cannot even see the damage they are a part of. All they see is green. I speak of damage to a system, that, if left pure will wrought, in general the highest degree of existence and the greatest of successes for our Nation and of it's peoples thereof who's Liberties are dependent upon of good and just government including but not limited to it's individual administrations. A Nation that once used reason to attain higher esteem and accolades rather than the brutish tactics employed even today in many lesser nations. Thought and merit that brought into being, a means of thrusting itself into a higher degree of existence which all said inhabitants have benefited since. Even now, although muted by a great degree, our lives are richer from a legacy inherited in a lessor form than yesterday because of the corruption wielded with impunity, that is designed to steal property, intellectually or tangible. Soon it will be complete, we will be degenerated into another form of society. Socialism, or in reality an oligarchcial despotism that cannibalizes it's own members. Our inherited way, even now, invites non official members entrance to our fantastic motor for excellence, improving themselves and others here because of the expected Honesty and Just system for trade that was designed to reward hard work and the intrepid intellectual members of our race, rather than the ways of cynical monsters over human history that take by way of brutish tactics and deceit because they lack the wherewithal for discovery.
    Make no mistake these monsters whom wield their proverbial quills like demonic wraiths are paid to complete the dirty deed of planting our Constitution into a shallow grave.
    22 Jan 2014, 08:35 AM Reply Like
  • flshock
    , contributor
    Comment (1) | Send Message
    is it true that a member of the FDA is actually an investor / stock holder of a competitors drug? Oh and also that drug is already approved for the exact same thing that AMRN is attempting to gain approval for?


    Just asking................. does anyone know????


    I bought in based on promises and recommendations, now I'm sick to my stomach, but I still truly believe in this company.. and I'm sticking with them... come'on guys...... get it right
    9 Feb 2014, 04:43 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs